VYNE
VYNE Therapeutics Inc.
$0.65
-0.02 (-2.99%)
At close · Jul 8
Market Cap
$21.69M
Shares
33,352,858
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-21 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-03-11 | — | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2026-01-30 | — | |
| 8-K | 2025-12-17 | — | |
| 8-K | 2025-12-12 | — | |
| DEF 14A | 2025-11-12 | 2025-12-12 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-12 | 2025-09-11 | |
| 8-K | 2025-08-14 | 2025-08-11 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-12-12 | — | |
| DEF 14A | 2024-11-12 | 2024-12-12 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-12 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| 10-K | 2024-03-01 | 2023-12-31 | |
| 8-K | 2024-02-29 | — | |
| 8-K | 2024-01-03 | 2023-12-29 | |
| 8-K | 2023-12-13 | 2023-12-11 | |
| DEF 14A | 2023-11-13 | 2023-12-13 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-13 | — | |
| 8-K | 2023-10-30 | 2023-10-27 | |
| 8-K | 2023-08-14 | — | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| 8-K | 2023-05-11 | — | |
| 8-K | 2023-05-01 | 2023-04-28 | |
| 10-K | 2023-03-14 | 2022-12-31 | |
| 8-K | 2023-03-09 | — | |
| 8-K | 2023-02-28 | 2023-02-27 | |
| 8-K | 2023-02-10 | 2023-02-08 | |
| 8-K | 2023-01-17 | — | |
| 8-K | 2023-01-12 | — | |
| DEF 14A | 2022-11-25 | 2023-01-12 | |
| 10-Q | 2022-11-14 | 2022-09-30 |
Showing 1–50 of 132 filings